MLB investigators to question Dodgers team doctor Neal ElAttrache after report ties him to alleged PED support for Conor McGregor

Major League Baseball investigators are expected to question Los Angeles Dodgers team physician Neal ElAttrache following a report that he supported performance-enhancing drug use by UFC fighter Conor McGregor during McGregor’s recovery from an injury, according to the New York Times and as summarized by CBS Sports. The matter, as described in the reporting, is aimed at understanding ElAttrache’s role and any professional relationship that may have overlapped with PED-related activity.

ElAttrache is widely associated with pro sports medicine, serving as the Dodgers’ team doctor. The reporting also notes that he is the team doctor for the NFL’s Los Angeles Rams, underscoring that the inquiry, if it expands, could involve cross-league medical questions about the intersection of treatment, supplements, and banned substances.

The allegation at the center of the story involves McGregor’s recovery period. As presented in the CBS report, the claim is not that McGregor is a Dodgers player, but rather that a team physician with credentials in Major League Baseball may have been involved in medical or performance-related guidance connected to PED use by a high-profile athlete. MLB’s investigative focus typically centers on matters tied to baseball rules and league integrity, including whether any PED activity connects to baseball personnel, medical staff, or the league’s anti-doping framework.

Neither MLB nor the Dodgers have been described in the available summary as issuing a formal statement in response. With only the CBS account and the referenced New York Times report to rely on, details remain limited about what, exactly, investigators are seeking to confirm, whether documents or other testimony are involved, and what timeline the inquiry follows. Additional reporting or an official league development would be needed to clarify the scope and status of any questioning.

The Dodgers, of course, are in the business of managing injuries and returning players to performance, a process that often relies on team medical staff and outside expertise. If ElAttrache is questioned, it could raise broader questions about how MLB views physician involvement in PED-related conduct outside baseball, even when the conduct is alleged to have occurred in a different sport and under different regulatory bodies.

In the immediate term, the situation is most likely to become a league integrity story rather than a competitive one, at least until any findings are reported. MLB’s anti-doping posture, combined with the prominence of both McGregor and ElAttrache, means the inquiry could draw attention well beyond Los Angeles and the medical training room.

What to watch next is whether MLB provides any confirmation or procedural detail, whether the Dodgers respond with a statement about their medical protocols and cooperation with investigators, and whether ElAttrache’s involvement, if any, is tied to specific conduct or communications that can be evaluated under MLB’s rules. Until then, the case remains an allegation-driven inquiry centered on reported medical support for PED use during an injury recovery.